Hitoshi Kawazoe

11PUBLICATIONS
23CO-AUTHORS
Pacific Peoples medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsPredictive and prognostic markersMedical biochemistry - nucleic acids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 25, 2026
Association of Probiotics with Effectiveness of Nivolumab or Pembrolizumab in Patients with Esophageal Cancer Taking Proton Pump Inhibitors: A Multicenter Retrospective Study.

|Apr 03, 2026
Association of immune-related adverse events with survival in patients receiving immune checkpoint inhibitor plus chemotherapy for lung cancer.

Shinya Takada, Izumi Nasu, Ryuji Uozumi

|Feb 06, 2026
Proton-pump inhibitors and palbociclib or abemaciclib in endocrine-sensitive breast cancer treatment.

Shinya Takada, Kaori Takahashi, Ryuji Uozumi

|Nov 21, 2025
Proton Pump Inhibitors Attenuate the Effectiveness of Nivolumab Monotherapy in Patients with Advanced Gastric Cancer: A Retrospective Study.

Mikumi Yamaguchi, Hitoshi Kawazoe, Yusuke Kasai

|Feb 10, 2024
Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer.

Kaori Takahashi, Ryuji Uozumi, Toru Mukohara

|Nov 20, 2023
Pharmacokinetics/pharmacodynamics analysis and establishment of optimal dosing regimens using unbound cefmetazole concentration for patients infected with Extended-Spectrum β-lactamase producing Enterobacterales (ESBL-E).

Takaya Namiki, Yuta Yokoyama, Hideki Hashi

Pageof 2

Frequent Collaborators

3 joint publications

Yuta Yokoyama

3 joint publications

Aya Jibiki

3 joint publications

Sayo Suzuki

3 joint publications

Tomonori Nakamura